Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2008
06/24/2008US7390802 Substituted lactams as inhibitors of Aβ protein production
06/24/2008US7390798 Carboxamide spirolactam CGRP receptor antagonists
06/24/2008US7390797 Fused indazole compounds
06/19/2008WO2008073687A2 Compounds and compositions as protein kinase inhibitors
06/19/2008WO2008073480A1 Compounds and compositions as kinase inhibitors
06/19/2008WO2008073461A2 Ion channel modulators
06/19/2008WO2008073306A1 Organic compounds
06/19/2008WO2008072784A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
06/19/2008WO2008072745A1 Process for production of anthranilamide compound
06/19/2008WO2008072743A1 Method for producing anthranilamide compound by using novel pyrazole compound as intermediate
06/19/2008WO2008072724A1 Pyrazole derivative
06/19/2008WO2008072658A1 2-phenylnicotinic acid derivative
06/19/2008WO2008072053A2 Substituted arylpyrazoles
06/19/2008WO2008071937A1 Novel fluorescent kinase ligands and assays employing the same
06/19/2008WO2008071931A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases
06/19/2008WO2008071927A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases
06/19/2008WO2008071665A1 A nicotinamide derivative useful as p38 kinase inhibitor
06/19/2008WO2008071664A1 Nicotinamide derivative used as a p38 kinase inhibitor
06/19/2008WO2008071646A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008WO2008071453A1 1,2-diarylacetylene derivatives of acyltryptophanols
06/19/2008WO2008071451A1 Dihydropyridine derivatives useful as protein kinase inhibitors
06/19/2008WO2008071397A1 Aromatic 1,4-di-carboxylamides and their use
06/19/2008WO2008051873A3 Phenylurea compounds as soluble epoxide hydrolase inhibitors
06/19/2008WO2008051541A3 Process for preparing anhydrous aripirazole type i
06/19/2008WO2008049123A3 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases
06/19/2008WO2008044217A3 2-aminocarbonyl-pyridine derivatives
06/19/2008WO2008044027A3 Pharmaceutical compounds having hsp90 inhibitory or modulating activity
06/19/2008WO2008043544A8 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
06/19/2008WO2006078621A9 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
06/19/2008US20080146811 peptidomimetics and non-peptides that inhibit the activity of Factor XIa; purified human Factor XI protein mutants
06/19/2008US20080146810 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
06/19/2008US20080146808 Antiapoptosis; cancers; inhibiting the caspases;
06/19/2008US20080146740 Process for the controlled increase in the molecular weight of polyethylenes
06/19/2008US20080146647 Acetylene derivatives having mglur 5 antagonistic activity
06/19/2008US20080146635 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion
06/19/2008US20080146616 Indoles Useful in the Treatment of Inflammation
06/19/2008US20080146614 Therapeutic Agents
06/19/2008US20080146613 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
06/19/2008US20080146610 Isotopically substituted proton pump inhibitors
06/19/2008US20080146607 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents
06/19/2008US20080146599 receptor tyrosine kinase inhibitors such as 2-chloro-N-{3-[(4,6-diaminopyrimidin-5-yl)ethynyl]phenyl}benzenesulfonamide, used as angiogenesis inhibitors in mammals
06/19/2008US20080146596 Such as (R)-2-(4-((3'-chlorobiphenyl-4-yl)(hydroxy)methyl)piperidin-1-yl)pyrimidin-5-ol for treating age-associated memory impairment, Alzheimer's disease, attention-deficit/hyperactivity disorder, autism, Down syndrome, Fragile X syndrome, Huntington's disease, Parkinson's disease, or schizophrenia
06/19/2008US20080146595 Non-nucleoside reverse transcriptase inhibitors
06/19/2008US20080146594 Thrombopoietin activity modulating compounds and methods
06/19/2008US20080146587 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands
06/19/2008US20080146586 antitumor and antibiotic activity which can be used as anticancer agents; exhibit specific and intensive activity in inhibiting tyrosine kinase of the growth factor receptor, and show negligible side-effects compared
06/19/2008US20080146582 Diazabicyclic Aryl Derivatives and Their Use as Chinolinergic Ligands at the Nicotinic Acetylcholine Receptors
06/19/2008US20080146578 Indolylmaleimide derivatives
06/19/2008US20080146574 Heterocycle Substituted Carboxylic Acids
06/19/2008US20080146568 Spiro-piperidine derivatives
06/19/2008US20080146560 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(5-tert-butylisoxazol-3-yl)urea; treatment of tyrosine kinase-induced diseases and conditions, such as angiogenesis, cancer, tumour formation, growth and propagation, arteriosclerosis, ocular diseases, such as age-induced macular degeneration
06/19/2008US20080146559 useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; useful in treating obesity
06/19/2008US20080146558 4,5,6,7-Tetrahydro-Thieno [3,2-C] Pyridine Derivatives
06/19/2008US20080146552 e.g. 2-(3-chloro-pyridin-2-yl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid [4-chloro-2-(2-methanesulfinyl-propylcarbamoyl)-6-methyl-phenyl]-amide; controlling insects or representatives of the order Acarina
06/19/2008US20080146550 HETEROARYLACETAMIDE INHIBITORS OF FACTOR Xa
06/19/2008US20080146539 New carboxylic acid amides, the preparation thereof and their use as medicaments
06/19/2008US20080146538 exo-3-Bromo-N-((2S)-2-(4-fluorophenyl)-4-(3-(3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl)azetidin-1-yl}butyl)-N-methyl-5-(trifluoromethyl)benzamide;neurokinin NK/tachykinin receptor antagonist; neurodegenerative diseases, antidepressant; gastrointestinal disorder; analgesic, antiinflammatory agent
06/19/2008US20080145699 Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element
06/19/2008US20080145698 Compounds For Organic Electronic Devices
06/19/2008US20080145324 Lipophilic ultraviolet screening agent; tanning protectant in cosmetic and dermatologic products; topical; photoprotective effectiveness and solubility by adding at least one silicon-containing s-triazine compound substituted with two aminobenzoate or aminobenzamide groups
06/19/2008DE102006059710A1 Substituierte 4-Hydroxypyridine Substituted 4-hydroxypyridines
06/19/2008CA2672601A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
06/19/2008CA2672233A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
06/19/2008CA2672167A1 Dihydropyridine derivatives as useful as protein kinase inhibitors
06/19/2008CA2672101A1 Compounds and compositions as kinase inhibitors
06/19/2008CA2671984A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008CA2671478A1 Non-nucleoside reverse transcriptase inhibitors
06/19/2008CA2671473A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases
06/19/2008CA2671460A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases
06/19/2008CA2670728A1 Pyridine derivatives used as xiap inhibitors
06/19/2008CA2615345A1 Crystalline form of rabeprazole sodium
06/18/2008EP1932841A1 Sulfonamide compound
06/18/2008EP1932840A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
06/18/2008EP1932839A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/18/2008EP1932834A1 Aromatic 1,4-DI-Carboxylamides and their use
06/18/2008EP1932831A1 1,2-Diarylacetylene Derivatives of Acyltryptophanols
06/18/2008EP1931684A2 Oxazolidinone-quinolone hybrids as antibacterial compounds
06/18/2008EP1931657A2 Novel high affinity quinoline-based kinase ligands
06/18/2008EP1931654A2 Modulators of metabolism and the treatment of disorders related thereto
06/18/2008EP1931653A2 Therapeutic pyrrolidines
06/18/2008EP1931652A2 Amido compounds and their use as pharmaceuticals
06/18/2008EP1931647A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
06/18/2008EP1931646A2 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs
06/18/2008EP1931645A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
06/18/2008EP1931643A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides
06/18/2008EP1931641A2 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
06/18/2008EP1931640A2 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
06/18/2008EP1931637A2 Methods of modulating neurotrophin-mediated activity
06/18/2008EP1931632A2 Useful indole compounds
06/18/2008EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
06/18/2008EP1931341A2 Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxalase tyrosine inducers
06/18/2008EP1931336A1 Tetrahydro-indazolyl cannabinoid modulators
06/18/2008EP1931335A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators
06/18/2008EP1758885B1 Diastereoselective addition of lithiated n-methylimidazole on sulfinimines
06/18/2008EP1594861B1 Triazole compounds and the therapeutic use thereof
06/18/2008EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
06/18/2008EP1485378B1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/18/2008EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
06/18/2008CN101203517A 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
06/18/2008CN101203510A Carbon-linked substituted piperidines and derivatives thereof used as histamine H3 antagonists
1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 1080